NASDAQ:ANIX
Anixa Biosciences Inc. Stock News
$2.42
-0.245 (-9.21%)
At Close: May 24, 2024
Anixa Biosciences' Covid-19 Compounds Expected to be Effective Against the Delta Variant
08:30am, Wednesday, 25'th Aug 2021
SAN JOSE, Calif., Aug. 25, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced to
Anixa Biosciences Congratulates Director, Dr. Arnold Baskies for His Appointment to the WHO's Global Breast Cancer Initiative
08:30am, Monday, 23'rd Aug 2021
SAN JOSE, Calif., Aug. 23, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced t
Anixa Biosciences Announces Issuance of U.S. Patent for Ovarian Cancer Vaccine Technology
08:30am, Wednesday, 18'th Aug 2021
SAN JOSE, Calif., Aug. 18, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced to
ANIX Stock Price: Over 15% Increase Pre-Market Explanation
08:20am, Thursday, 27'th May 2021
The stock price of Anixa Biosciences Inc (NASDAQ: ANIX) increased by over 15% pre-market. This is why it happened.
Anixa Biosciences Announces Support from the National Cancer Institute for Ovarian Cancer Vaccine Developed by Cleveland Clinic
08:30am, Wednesday, 26'th May 2021
SAN JOSE, Calif., May 26, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced tod
Anixa Biosciences and Moffitt Cancer Center Receive Additional Information Request from US FDA for CAR-T IND Application
08:30am, Thursday, 20'th May 2021
SAN JOSE, Calif., May 20, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced tod
OntoChem Assigns Anixa Covid-19 Drug Discovery Project to MolGenie
08:30am, Friday, 07'th May 2021
HALLE (SAALE), Germany, May 7, 2021 /PRNewswire/ -- OntoChem GmbH, a German Life Science IT company, announced today that it has assigned its drug discovery technologies and assets, including its dru
Anixa's Stock Craters As FDA Slaps Clinical Hold On CAR-T Program
12:58pm, Monday, 19'th Apr 2021
Anixa Biosciences Inc (NASDAQ: ANIX) shares drop after the FDA has requested additional information on its Chimeric Antigen Receptor-T cell therapy (CAR-T) being developed in partnership with Moff
Anixa Biosciences and Moffitt Cancer Center Report US FDA Request of Additional Information for CAR-T Therapy
08:30am, Monday, 19'th Apr 2021
SAN JOSE, Calif., April 19, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced t
Anixa Biosciences and OntoChem Enter Next Stage of Development for Covid-19 Therapeutic
08:30am, Monday, 05'th Apr 2021
SAN JOSE, Calif., April 5, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced to
Anixa Biosciences Increases Previously Announced Bought Deal Offering of Common Stock to $22.5 Million
10:00pm, Monday, 22'nd Mar 2021
SAN JOSE, Calif., March 22, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX) ("Anixa" or the "Company"), a biotechnology company focused on the treatment and prevention of cancer and inf
Anixa Biosciences Announces Issuance and Publication of European Patent for Ovarian Cancer Vaccine Technology
08:30am, Friday, 12'th Mar 2021
SAN JOSE, Calif., March 12, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced t
Anixa and OntoChem Announce Identification of Additional Covid-19 Compounds
01:00pm, Thursday, 13'th Aug 2020
Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, today announced that it and partner OntoChem have identified
Anixa Biosciences Breast Cancer Vaccine Technology Nearing FDA Submission
01:00pm, Tuesday, 28'th Jul 2020
Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, today announced that its prophylactic breast cancer vaccine i
2020 Insights into the Cancer Vaccines Market - Pipeline Analysis Report - ResearchAndMarkets.com
12:00am, Wednesday, 22'nd Jul 2020
The
